Cannabis Doesn’t Increase Creativity but Rather How Creative You Think You Are
by Chane Leigh
Cannabis is a hot topic in the medical and pharmaceutical industries, with 33 U.S. states now having permitted the plant as a treatment for various illnesses/ailments. Legalization is spreading further afield, too. The European cannabis market is slowly but surely taking off and Canada completely legalized the plant in October under the terms of the Cannabis Act (Bill C-45).
By the year 2026, the global medical cannabis market is predicted to inflate at a Compound Annual Growth Rate (CAGR) of 29.3 percent; reaching a $56.7 billion valuation. Cancer, chronic pain, seizures, HIV/AIDS and nausea are just a handful of the most commonly diagnosed conditions that can be treated using cannabis.
Although research has been halted by the U.S. Government’s prohibitionist approach to cannabis, more research is being unearthed on a daily basis into the plant’s suitability as a pharmaceutical aid.
Let’s take a look at some of the most recent cannabis research discoveries worth talking about:
According to a study straight out of Washington State University, government regulators could benefit from using their latest string of research discoveries to spotlight the plant’s medical potential. Since the Food and Drug Administration (FDA) is clamping down on companies that make commercial health claims about cannabis, hemp, and CBD-containing products, it is crucial that fresh research is able to support those claims.
The WSU’s genetic analysis into the plant’s medical properties and its chemical characteristics are said to be the first investigation of its kind. Existing methods are not sufficient to support medical claims about the plant and its derivatives, says a professor at the university’s Institute for Biological Chemistry, Mark Lange.
He says that regulators usually hone-in on the amount THC (tetrahydrocannabinol) contained in cannabis, without even giving any thought to the 100+ other cannabinoids contained in the plant. His team’s findings were published in the journal Plant Physiology.
“There is a reason why all these strains have different names — because a lot of them are very different,” explained Lange. “But some strains with different names are actually very similar. The bottom line is there is a lot of confusion.”
Lange and his group of analysts looked into the genetic sequences of nine commercial strains of weed. What they discovered was that each strain consisted of a unique genetic composition, which demonstrated the plant’s terpene and cannabinoid production.
Perhaps the most beneficial aspect of the WSU research was the clear distinction between cannabis and hemp plants that Lange and his team succeeded in drawing up.
From June 6, 2016, to May 5, 2018, the University of New Mexico conducted a study where a total of 3,341 medical cannabis patients utilized a software called Vivo. Using the mobile-accessible device, 19,910 self-reported cannabis sessions were submitted by the study participants.
The ReleafApp was also used to input data relating to the specific type of cannabis being consumed by each person, e.g. concentrated forms of weed, topical solutions, dried bud/flower, edibles, and potent tinctures. In addition to this, the app logged information related to the product’s cannabinoid content, as well as whether the product was derived from the cannabis subspecies (indica or sativa), its effect on each patient’s symptom ratings and the chosen method of combustion to achieve such effects.
Levels of symptomatic relief were recorded before and after the administration of the drug. On average, patients rated symptom improvement across 27 categories at 3.5 on a scale of 11 points. Of all the products tried by the study subjects, dried flower was most effective.
Consumption of cannabis and hemp’s non-intoxicating cannabinoid CBD (cannabidiol) did not trigger any major changes in symptoms, nor did it produce unwanted side effects. THC, on the other hand, reportedly produced better overall relief from symptoms.
On June 1, the findings of an animal study carried out by Colorado State University researchers was published in the Journal of the American Veterinary Medical Association. A total of 16 dogs participated in the study, which collected data from 2016-2017. The aim of the study was to monitor the short-term effects of CBD on seizure frequency.
Nine dogs were administered with CBD and an additional seven dogs were treated with a placebo. During the one-year clinical trial, which saw 89 percent of the dogs experience a noticeable reduction in seizure frequency after receiving medical cannabis as a treatment.
Dr. Stephanie McGrath led the pilot study, which she described as “promising and exciting.” McGrath is a neurologist who works in the university’s James L. Voss Veterinary Teaching Hospital.
Cannabis and nuns are two things that aren’t normally lumped together, but a group of Californian women is changing that. A nun can be described as “a woman who belongs to a religious order and takes vows of poverty, chastity, and obedience,” reports Catholic Education. A nun’s vows are publicly accepted by religious superiors, and…
Medical cannabis is legal in 37 states, including our nation’s capital, Washington, DC. Nineteen states have legalized recreational or adult-use cannabis. Just because medical cannabis and recreational cannabis are legal in so many places doesn’t mean that the programs are uniform across the country. There are many existing differences between medical cannabis programs from state…
These days cannabis consumers have a lot of variety when choosing what cannabis strain they want to purchase. There are rare cannabis strains and more common cannabis strains, like with any other product. There is a plethora of Indica, Sativa, and hybrid cannabis strains available on both the recreational and medical cannabis markets. As research…
Cannabis has been making waves as an effective botanical approach to therapeutics and medication, but there is another substance worthy of just as much attention for its benefits and uses. The concept of adaptogens was first introduced in 1947 despite having been used by royal families from 2500-2700 BCE. Dr. Nicolai V. Lararev was a…
A pair of boxing legends teamed up for an unexpected collaboration, Texas’ medical cannabis program saw big gains, and a hemp study revealed troubling signs for the industry. Let’s dive into this week’s cannanews. Mike Tyson and Evander Holyfield Announce ‘Holy Ear’ Edibles 25 years ago, boxer Mike Tyson infamously bit off a part of…
Whether you live apart from loved ones or simply want a breather from the drama and political debates, spending Thanksgiving alone can…
All of the ways you can infuse cannabis into various recipes never cease to amaze me—particularly cannabis-infused syrup. THC syrup is a…